 - Chronic hepatitis C infection defined as a positive hepatitis C antibody and positive hepatitis C RNA at any time prior to study entry. NOTE: Candidates who are positive for hepatitis C antibody but who are hepatitis C virus HCV RNA negative are permitted in the study. Candidates who have been treated for hepatitis C must be HCV RNA negative for at least 24 weeks after completion of therapy to be eligible for the study. 